Decreased STAT1 Expression by Promoter Methylation in Squamous Cell Carcinogenesis-Reference-Cited by-同舟云学术

Decreased STAT1 Expression by Promoter Methylation in Squamous Cell Carcinogenesis

Published:2006-02-01 Issue:3 Volume:98 Page:181-189
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Xi Sichuan,Dyer Kevin F.,Kimak Mark,Zhang Qing,Gooding William E.,Chaillet J. Richard,Chai Raymond Liu,Ferrell Robert E.,Zamboni Beth,Hunt Jennifer,Grandis Jennifer Rubin

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/98/3/181/7688215/djj020.pdf

Reference42 articles.

1. Darnell JE Jr. STATs and gene regulation. Science1997 ; 277 : 1630 –5.

2. Yu H, Jove R. The STATs of cancer–new molecular targets come of age. Nat Rev Cancer2004 ; 4 : 97 –105.

3. Grandis JR, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, Pitt AS, et al. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro. J Clin Invest1998 ; 102 : 1385 –92.

4. Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, et al. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A1998 ; 95 : 7556 –61.

5. Huang S, Bucana CD, Van Arsdall M, Fidler IJ. Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells. Oncogene2002 ; 21 : 2504 –12.

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nuclear Matrix-associated Protein SMAR1 Attenuated Acute Graft-versus-host Disease by Targeting JAK-STAT Signaling in CD4+ T Cells;Transplantation;2023-10-11

2. Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications;Advances in Cancer Biology - Metastasis;2023-10

3. Interplay between signal transducers and activators of transcription (STAT) proteins and cancer: involvement, therapeutic and prognostic perspective;Clinical and Experimental Medicine;2023-09-29

4. Insight into Cancer Immunity: MHCs, Immune Cells and Commensal Microbiota;Cells;2023-07-18

5. Dysregulation in IFN-γ signaling and response: the barricade to tumor immunotherapy;Frontiers in Immunology;2023-05-18